000 01587 a2200445 4500
005 20250517093142.0
264 0 _c20180820
008 201808s 0 0 eng d
022 _a1097-6825
024 7 _a10.1016/j.jaci.2016.02.025
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aArts, Peer
245 0 0 _aImmunologic defects in severe mucocutaneous HSV-2 infections: Response to IFN-γ therapy.
_h[electronic resource]
260 _bThe Journal of allergy and clinical immunology
_c09 2016
300 _a895-898 p.
_bdigital
500 _aPublication Type: Case Reports; Letter; Research Support, Non-U.S. Gov't
650 0 4 _aAdult
650 0 4 _aFemale
650 0 4 _aHerpes Simplex
_xdrug therapy
650 0 4 _aHerpesvirus 1, Human
_xdrug effects
650 0 4 _aHerpesvirus 2, Human
_xdrug effects
650 0 4 _aHumans
650 0 4 _aInterferon-gamma
_ximmunology
650 0 4 _aMiddle Aged
650 0 4 _aRecombinant Proteins
_ximmunology
700 1 _avan de Veerdonk, Frank L
700 1 _avan der Lee, Robin
700 1 _aLangereis, Martijn A
700 1 _aGilissen, Christian
700 1 _avan Zelst-Stams, Wendy A G
700 1 _aHuynen, Martijn A
700 1 _avan der Meer, Jos W M
700 1 _avan Kuppeveld, Frank J
700 1 _aVeltman, Joris A
700 1 _aKullberg, Bart Jan
700 1 _aHoischen, Alexander
700 1 _aNetea, Mihai G
773 0 _tThe Journal of allergy and clinical immunology
_gvol. 138
_gno. 3
_gp. 895-898
856 4 0 _uhttps://doi.org/10.1016/j.jaci.2016.02.025
_zAvailable from publisher's website
999 _c25975367
_d25975367